To include your compound in the COVID-19 Resource Center, submit it here.

Deep Genomics: Letting AI take the wheel

Deep Genomics begins to lift the curtain on its AI discovery platform

Deep Genomics announced its first candidate in September, pulling back the curtain on its holistic AI-enabled discovery platform that is designed to identify viable antisense oligonucleotide candidates faster than traditional discovery methods.

CEO Brendan Frey and his team began developing Deep Genomics Inc.’s AI system in 2004 at the University of Toronto, where he is a professor of engineering and medicine. The company spun out of the university in 2015.

While other AI companies’ platforms often “solve just one part

Read the full 797 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers